Neurocrine Biosciences
NBIX
#1505
Rank
โ‚ฌ10.72 B
Marketcap
107,62ย โ‚ฌ
Share price
0.50%
Change (1 day)
-16.84%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Net assets

Net assets on the balance sheet as of December 2024 : โ‚ฌ2.39 Billion

According to Neurocrine Biosciences 's latest financial reports the company has โ‚ฌ2.39 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Neurocrine Biosciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$โ‚ฌ2.48 B23.26%
2023-12-31$โ‚ฌ2.01 B26.82%
2022-12-31$โ‚ฌ1.59 B31.23%
2021-12-31$โ‚ฌ1.21 B32.51%
2020-12-31$โ‚ฌ0.91 B61.05%
2019-12-31$โ‚ฌ0.56 B35.29%
2018-12-31$โ‚ฌ0.42 B35.5%
2017-12-31$โ‚ฌ0.31 B3.61%
2016-12-31$โ‚ฌ0.29 B-22.89%
2015-12-31$โ‚ฌ0.38 B126.22%
2014-12-31$โ‚ฌ0.17 B96.81%
2013-12-31$โ‚ฌ87.19 M-25.29%
2012-12-31$โ‚ฌ0.11 B152.26%
2011-12-31$โ‚ฌ46.26 M218.1%
2010-12-31$โ‚ฌ14.54 M426.98%
2009-12-31$โ‚ฌ2.75 M-89.51%
2008-12-31$โ‚ฌ26.3 M-67.64%
2007-12-31$โ‚ฌ81.29 M-65.92%
2006-12-31$โ‚ฌ0.23 B-27.57%
2005-12-31$โ‚ฌ0.32 B13.43%
2004-12-31$โ‚ฌ0.29 B-6.55%
2003-12-31$โ‚ฌ0.31 B44.81%
2002-12-31$โ‚ฌ0.21 B-38.96%
2001-12-31$โ‚ฌ0.35 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
โ‚ฌ1.82 B-23.82%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.58 B 299.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
-โ‚ฌ5.92 Million-100.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ13.21 B 451.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.11 B 29.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ81.97 B 3,317.27%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.39 B-83.45%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ33.72 Million-101.41%๐Ÿ‡บ๐Ÿ‡ธ USA